静脈内水分補給療法市場 - 世界の産業規模、シェア、動向、機会、予測、サービス別、成分別、最終用途産業別、地域別、競合別、2020年～2030年

静脈内（IV）水分補給療法の世界市場は、2024年に32億6,000万米ドルと評価され、予測期間中のCAGRは7.32%で、2030年までには49億8,000万米ドルに達すると予測されています。

静脈内（IV）水分補給療法は、静脈を通じて人の血流に直接水分、電解質、場合によっては薬剤を送り込む治療法です。脱水や様々な病状に対処するために一般的に使用されます。点滴による水分補給は、病気、発汗過多、嘔吐、下痢、水分摂取不足などによって起こる中等度から重度の脱水を治療するために行われることが多いです。静脈内輸液は体内の水分レベルを速やかに補充し、電解質バランスの回復と適切な臓器機能の維持を助けます。点滴静注療法は、胃腸炎、腎臓感染症、尿路感染症などの特定の病気によって生じる体液と電解質の不均衡を管理するのに役立ちます。電解質は必須ミネラル（ナトリウム、カリウム、カルシウム、マグネシウムなど）で、神経や筋肉の機能、体液バランス、pH調整など、さまざまな身体機能の維持に重要な役割を果たしています。静脈内水分補給療法は、腎機能障害、ホルモン障害、重度の嘔吐や下痢などの状態によって引き起こされる電解質レベルの不均衡を是正することができます。

主要な市場促進要因

手術手技の増加が市場成長を牽引

主要な市場課題

規制と法的考察

主要な市場動向

ウェルネスとライフスタイル用途の増加

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の静脈内（IV）水分補給療法市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サービス別（免疫力アップ、エネルギーアップ、スキンケア、片頭痛、その他）
  • 成分別（医薬品、非医薬品）
  • 最終用途産業別（病院・クリニック、ウェルネスセンター・スパ、在宅ヘルスケア、その他）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の静脈内（IV）水分補給療法市場の展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の静脈内（IV）水分補給療法市場の展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の静脈内（IV）水分補給療法市場の展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の静脈内（IV）水分補給療法市場の展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの静脈内（IV）水分補給療法市場の展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Core IV Therapy, LLC
• Cryojuvenate UK Ltd.
• B. Braun Medical Inc.
• Otsuka Pharmaceutical Co., Ltd.
• NexGen Health Inc
• JW Life Science Corporation
• Amanta Healthcare Ltd
• Baxter International Inc.
• Drip Hydration Inc
• Becton, Dickinson and Company

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Intravenous (IV) Hydration Therapy Market was valued at USD 3.26 Billion in 2024 and is expected to reach USD 4.98 Billion by 2030 with a CAGR of 7.32% during the forecast period. Intravenous (IV) Hydration Therapy is a medical treatment that involves delivering fluids, electrolytes, and sometimes medications directly into a person's bloodstream through a vein. It is commonly used to address dehydration and various medical conditions. Intravenous (IV) hydration is often employed to treat moderate to severe dehydration, which can occur due to illnesses, excessive sweating, vomiting, diarrhoea, or inadequate fluid intake. IV fluids quickly replenish the body's fluid levels, helping to restore electrolyte balance and maintain proper organ function. IV hydration therapy can help manage the fluid and electrolyte imbalances that can arise from certain illnesses, such as gastroenteritis, kidney infections, and urinary tract infections. Electrolytes are essential minerals (such as sodium, potassium, calcium, and magnesium) that play a crucial role in maintaining various bodily functions, including nerve and muscle function, fluid balance, and pH regulation. IV hydration therapy can correct imbalances in electrolyte levels, which can be caused by conditions like kidney dysfunction, hormonal disorders, or severe vomiting and diarrhoea.

Key Market Drivers

Increasing Surgical Procedures Drives the Market Growth

Increasing surgical procedures drive the growth of the global Intravenous (IV) hydration therapy market primarily due to the essential role that IV hydration therapy plays in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. Prior to surgery, patients often need to fast or restrict their oral fluid intake, which can lead to dehydration. IV hydration therapy is used to ensure that patients are adequately hydrated before surgery, which is important for maintaining stable blood pressure, optimal organ function, and overall patient well-being. During surgery, patients may experience fluid and electrolyte shifts due to blood loss, fluid shifts, and the effects of anaesthesia. IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's ability to respond to surgical stress and anaesthesia. After surgery, patients may experience nausea, vomiting, and limited oral intake, which can lead to further dehydration. IV hydration therapy is essential for supporting the recovery process, preventing complications, and facilitating the healing process. Proper hydration and electrolyte balance are key factors in reducing the risk of postoperative complications, such as infections, wound healing issues, and organ dysfunction. IV hydration therapy can help minimize these risks and improve overall patient outcomes. Adequate hydration and electrolyte balance are associated with faster healing and recovery times. IV hydration therapy can help patients regain their strength and energy more quickly after surgery, allowing them to resume normal activities sooner.

Key Market Challenges

Regulatory and Legal Considerations

Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market due to the need to ensure patient safety, maintain quality standards, and adhere to local and international regulations governing medical practices and the administration of medical treatments. Healthcare providers who administer IV hydration therapy need to hold the appropriate licenses and certifications to perform medical procedures. These requirements vary by jurisdiction and can involve extensive training and education. Obtaining and maintaining these credentials can be time-consuming and costly. Different healthcare professionals have varying scopes of practice when it comes to administering IV therapies. Legal and regulatory frameworks may restrict who is allowed to perform IV therapy, which can impact the availability and accessibility of the treatment.

Key Market Trends

Rise of Wellness and Lifestyle Use

In global Intravenous (IV) Hydration Therapy market, The rise of wellness and lifestyle use is a significant trend in the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. The trend has expanded the potential consumer base beyond traditional medical indications. Wellness-conscious individuals, athletes, professionals with demanding lifestyles, and those seeking quick recovery from fatigue or exertion are exploring IV hydration therapy for its perceived benefits. The trend aligns with a growing interest in holistic health and well-being. Consumers are viewing IV hydration therapy as a complementary approach to maintaining overall health, alongside other wellness practices such as diet, exercise, and stress management. Many individuals seek IV hydration therapy to boost energy levels and combat fatigue. The treatment is believed to provide a quick and efficient way to rehydrate and replenish essential nutrients, leading to improved vitality and performance. IV hydration therapy is often marketed as a way to support the immune system, particularly during times of stress, travel, or exposure to illness. Consumers may opt for IV treatments to enhance their body's defenses and well-being. IV hydration therapy is perceived as a convenient and time-efficient method of receiving hydration and nutrients. This appeals to busy individuals who seek immediate results.

Key Market Players

• Core IV Therapy, LLC
• Rejuvenated UK Ltd.
• B. Braun Medical Inc.
• Otsuka Pharmaceutical Co., Ltd.
• NexGen Health Inc
• JW Life Science Corporation
• Amanta Healthcare Ltd
• Baxter International Inc.
• Drip Hydration Inc.
• Becton, Dickinson and Company

Report Scope:

In this report, Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service:

• Immune Boosters
• Energy Boosters
• Skin Care
• Migraine
• Others

Intravenous (IV) Hydration Therapy Market, By Component:

• Medicated
• Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-User:

• Hospitals & Clinics
• Wellness Centers & Spas
• Home Healthcare
• Others

Intravenous (IV) Hydration Therapy Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

Global Intravenous (IV) Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous (IV) Hydration Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
  • 5.2.2. By Component (Medicated, Non-medicated)
  • 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Intravenous (IV) Hydration Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Component
  • 6.2.3. By End-Use Industry
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End-Use Industry
  • 6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End-Use Industry
  • 6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End-Use Industry

7. Europe Intravenous (IV) Hydration Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Component
  • 7.2.3. By End-Use Industry
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End-Use Industry
  • 7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End-Use Industry
  • 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End-Use Industry
  • 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End-Use Industry
  • 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End-Use Industry

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Component
  • 8.2.3. By End-Use Industry
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End-Use Industry
  • 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End-Use Industry
  • 8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End-Use Industry
  • 8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End-Use Industry
  • 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End-Use Industry

9. South America Intravenous (IV) Hydration Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Component
  • 9.2.3. By End-Use Industry
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End-Use Industry
  • 9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End-Use Industry
  • 9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End-Use Industry

10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Component
  • 10.2.3. By End-Use Industry
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End-Use Industry
  • 10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End-Use Industry
  • 10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End-Use Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Core IV Therapy, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (In case of listed companies)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Cryojuvenate UK Ltd.
• 15.3. B. Braun Medical Inc.
• 15.4. Otsuka Pharmaceutical Co., Ltd.
• 15.5. NexGen Health Inc
• 15.6. JW Life Science Corporation
• 15.7. Amanta Healthcare Ltd
• 15.8. Baxter International Inc.
• 15.9. Drip Hydration Inc
• 15.10. Becton, Dickinson and Company

16. Strategic Recommendations

17. About Us & Disclaimer